MYD88 and metabolic dysfunction-associated steatotic liver disease: Its interaction with the LR4/MyD88/NF-κB signaling pathway leads to elevated secretion of inflammatory cytokines and activation of M1 macrophages, thus promoting NAFLD development (Carpino et al., 2020).